-+ 0.00%
-+ 0.00%
-+ 0.00%

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Gets NMPA Acceptance for FZ-P001 Phase II Lung Cancer Trial

Reuters·12/28/2025 10:22:35

Please log in to view news